01652.HK
Fusen Pharmaceutical Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.74
−5.73%Margins
Gross margin
41.7%
EBITDA margin
2.3%
EBIT margin
-5.5%
Net margin
-34.3%
FCF margin
13.5%
-51.3%
Return on equity
-14.3%
Return on assets
-4.3%
Return on invested capital
0.41x
Asset turnover
HKD 142.1M
Cash from operations
HKD 0.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026